Mitacs Accelerate supports 3C Therapeutics–UBC research collaboration

On October 9, 2025, Mitacs Accelerate awarded support for a research collaboration between 3C Therapeutics and Professor David Perrin’s laboratory at the University of British Columbia.

The project focuses on developing targeted cyclic peptides for delivery of protein degraders and supports research training through a Mitacs internship.